Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Iodine-radioactive/lenvatinib

Obstructive coronary artery disease, peripheral vascular disease and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sukrithan V, et al. Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib. Case Reports in Endocrinology 2023: Jan 2023. Available from: URL: https://dx.doi.org/10.1155/2023/8841696 Sukrithan V, et al. Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib. Case Reports in Endocrinology 2023: Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1155/​2023/​8841696
Metadaten
Titel
Iodine-radioactive/lenvatinib
Obstructive coronary artery disease, peripheral vascular disease and lack of efficacy
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-52070-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Ferrous-sulfate

Case report

Cefotaxime

Case report

Tranexamic-acid

Case report

Multiple drugs